Sol-Gel Technologies Ltd.:
Clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Current pipeline leverages proprietary technology platform. Two P3 readouts in 2019: Rosacea (Epsolay) mid-year; Acne (TWIN) year-end.
100MM - 500MM
Sol-Gel Technologies Ltd
7 Golda Meir St.
NESS-ZIONA, State/Province 7403650
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Sol-Gel Analyst & Investor Day 2019 in NYC
July 25, 2019
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by